Pharmaceuticals and personal care products in the environment: what are the big questions? - Test2 - elhamkhani - TriplyDB

Pharmaceuticals and personal care products in the environment: what are the big questions?

Pharmaceuticals and personal care products in the environment: what are the big questions?

http://www.wikidata.org/entity/Q26859139

about

Implementing ecopharmacovigilance in practice: challenges and potential opportunities Current perspectives on the use of alternative species in human health and ecological hazard assessments Detection and drivers of exposure and effects of pharmaceuticals in higher vertebrates Tracking pan-continental trends in environmental contamination using sentinel raptors-what types of samples should we use?Approaches to the Development of Human Health Toxicity Values for Active Pharmaceutical Ingredients in the Environment Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments Quantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetine What is conservation physiology? Perspectives on an increasingly integrated and essential science(†)Hidden drivers of low-dose pharmaceutical pollutant mixtures revealed by the novel GSA-QHTS screening method Ecotoxicity of climbazole, a fungicide contained in antidandruff shampoo Current concepts in neuroendocrine disruption.Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems.Ecopharmacovigilance: Current state, challenges, and opportunities in China Bioinformatics and Drug Discovery.Ethinyl estradiol and other human pharmaceutical estrogens in the aquatic environment: a review of recent risk assessment data Exposure and food web transfer of pharmaceuticals in ospreys (Pandion haliaetus): Predictive model and empirical data.Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms.Are harmful algal blooms becoming the greatest inland water quality threat to public health and aquatic ecosystems?Linking field-based metabolomics and chemical analyses to prioritize contaminants of emerging concern in the Great Lakes basin.An Integrated Experimental and Computational Approach for Characterizing the Kinetics and Mechanism of Triadimefon Racemization.Pharmaceuticals and personal care products in waters: occurrence, toxicity, and risk.Environmental designer drugs: when transformation may not eliminate risk.Behavioural and physiological responses of birds to environmentally relevant concentrations of an antidepressant.Risks of hormonally active pharmaceuticals to amphibians: a growing concern regarding progestagens.Medicines, shaken and stirred: a critical review on the ecotoxicology of pharmaceutical mixtures.Potential ecological footprints of active pharmaceutical ingredients: an examination of risk factors in low-, middle- and high-income countries.Bioaccumulation and trophic dilution of human pharmaceuticals across trophic positions of an effluent-dependent wadeable stream.Comparative pharmacology and toxicology of pharmaceuticals in the environment: diphenhydramine protection of diazinon toxicity in Danio rerio but not Daphnia magna Estrogenic and anti-estrogenic activity of off-the-shelf hair and skin care products Routes of uptake of diclofenac, fluoxetine, and triclosan into sediment-dwelling worms.Pharmaceuticals May Disrupt Natural Chemical Information Flows and Species Interactions in Aquatic Systems: Ideas and Perspectives on a Hidden Global Change.A framework for screening sites at risk from contaminants of emerging concern.Toward the definition of specific protection goals for the environmental risk assessment of chemicals: A perspective on environmental regulation in Europe.Emerging pollutant mixture mineralization by TiO2 photocatalysts. The role of the water medium.Pesticides in Drinking Water - The Brazilian Monitoring Program.Identification and structural elucidation of ozonation transformation products of estrone.Consumer-perceived risks and choices about pharmaceuticals in the environment: a cross-sectional study.Risk-based prioritization of pharmaceuticals in the natural environment in Iraq.Age matters: Developmental stage of Danio rerio larvae influences photomotor response thresholds to diazinion or diphenhydramine One-pot synthesis of carbon supported calcined-Mg/Al layered double hydroxides for antibiotic removal by slow pyrolysis of biomass waste.

P2860

Q24608788-9FA3D99E-4E71-4683-9637-3735613C717C Q26825743-5C1EB874-0A91-4435-A0BD-B3925B761845 Q26859188-F7E3277D-640C-4F70-B39C-FB5F21A287D6 Q27316749-F0C049FA-30AF-4661-B67B-C1C67FC6C1D7 Q28082159-27AB6C52-51F6-472C-97FF-A9A266AF0DC4 Q28384182-0126A561-1972-4813-B57E-FA7F950591EC Q28543995-6935070A-F5F7-4640-9147-0D73B146CA70 Q28601774-B2C05F7B-8B1B-4D35-98F8-6600BCA49927 Q28831097-4F7EB054-0E82-4684-A78C-A9EE4ED21D61 Q29540625-4D45FB1B-EFAF-4AE3-84D7-FAB4F926193B Q30384415-33415A87-FE78-4432-8A23-A1EBA5F5A541 Q30390250-3CF322DA-0642-4800-8457-CD10F3B2A48C Q30392270-01DF9CC8-7F4F-4634-BD61-05B8882815E2 Q30395256-F938A8F6-F2CF-4A22-A757-088D082FE448 Q30743440-89811346-D2EA-4A48-B927-640874FBBFB3 Q30840444-30C8B37B-F8AE-4E64-AE64-CA651C4B6694 Q30870407-5728FB86-F0E6-45FB-B8E2-497ED7A168E5 Q31037093-B830AF42-6909-458D-9632-2CA5249F14C3 Q31065039-7E6329F0-3738-47D5-9307-8B3418D2AE2A Q31118913-AC6F4233-A685-4FC9-A65B-398880DDFBF5 Q33764240-5A57531C-54F6-4794-94DA-9575D25AB87A Q34379712-D16C43C2-99CA-404B-B554-ADA5CAA7394B Q34423521-C122800E-3205-487D-A877-7F8E9AE43465 Q34423532-EEE55267-ED4C-4F5D-BFC0-23C012C51A40 Q34423557-105F26B1-492A-42F2-A8B0-D781F7A1959B Q34423563-42D31292-3FDF-447C-8429-55B7A9E9438E Q34423573-AA7ED8FB-B64B-4A4A-B92A-9FFCB8524D67 Q34871672-D5C066F0-E5D4-40AD-AECD-07CDD065BF35 Q35054696-35288637-A9FA-408A-91C3-25D8B5C56D8D Q35609561-68928BAC-4E44-4C1D-AC88-C211B4651605 Q35842680-AEF375C5-6594-49CB-BF6E-E2DD3BC66C22 Q35852219-9998BE88-038F-452B-B5E4-6A8FC60301A6 Q36034850-D25778CB-2391-4482-B20E-9164897527B9 Q36191536-6E6441F8-5262-4740-90CF-7DA52574AC0E Q36245531-0FBF4637-2DE2-4B3E-82F0-3BFC3DA1F566 Q36814965-75C43B3F-98FD-4DDD-9BAD-5A13B1ABF771 Q36922660-DE777802-96DD-4625-812A-F3C469000650 Q37116450-2420F8E6-4C8F-49DC-911A-E2B38021EB5D Q37141525-2F16E93B-6830-46C7-AB64-BA2451594593 Q37522511-DB6BAE60-5B85-4CF2-A99A-E51E86544EBB

P2860

Pharmaceuticals and personal care products in the environment: what are the big questions?

http://www.wikidata.org/entity/Q26859139

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pharmaceuticals and personal c ...... t: what are the big questions?

@ast

Pharmaceuticals and personal c ...... t: what are the big questions?

@en

Pharmaceuticals and personal c ...... t: what are the big questions?

@nl

type

label

Pharmaceuticals and personal c ...... t: what are the big questions?

@ast

Pharmaceuticals and personal c ...... t: what are the big questions?

@en

Pharmaceuticals and personal c ...... t: what are the big questions?

@nl

prefLabel

Pharmaceuticals and personal c ...... t: what are the big questions?

@ast

Pharmaceuticals and personal c ...... t: what are the big questions?

@en

Pharmaceuticals and personal c ...... t: what are the big questions?

@nl

P1433

Q26859139-04B536D4-34DB-4AAB-B211-CE0BFF79504C

P1476

Q26859139-0F5130BB-8F07-4B2D-B725-79D88211662B

P2093

Q26859139-16F0857D-7458-4044-92D1-9D9F49E0594F

Q26859139-1AE28011-17CB-4B2F-B108-368E157F7B16

Q26859139-20E89063-E65F-4F47-ABF5-0B84B6BFC713

Q26859139-267FF756-7439-490A-8C08-489103577DCE

Q26859139-28B13C2A-F37C-48AE-BD23-12A24BD5D959

Q26859139-2D2FC7B4-EDAA-4AF9-9131-4C70B3F3F3A2

Q26859139-2E5E500A-7F36-4F87-877F-4B690C252933

Q26859139-36353499-914B-4FE9-84EF-49F14D6FC73E

Q26859139-4592C51B-756F-44C1-B9CA-EFA38AC15A3E

Q26859139-49584F39-6182-4EC7-A53C-AF8498CDFEC4

P275

Q26859139-026A62E9-8556-476D-AB30-E723D075A963

P2860

Q26859139-03DB5F60-1272-4725-B6B7-5BA4B0406926

Q26859139-0567BDFE-E738-4CC1-A0B1-2304CE96986E

Q26859139-089395B4-6C40-4B0F-B839-9CF9D8DC7025

Q26859139-09F70E21-7A88-4FEC-84EA-59BAF3AE1532

Q26859139-11D075C1-CFA7-4AA6-BC70-5651BB253E51

Q26859139-12451C5B-1D3D-4B65-A802-45259BAA24DF

Q26859139-1635E328-797C-4DC5-9A1A-18122B87E0B5

Q26859139-1D87513D-F479-41E1-AEEA-9DDA3C17344C

Q26859139-231B0D19-E1B9-448B-BB43-6D87EBD7BE78

Q26859139-2393E1C9-B521-4C25-B7D6-05D450338537

P304

Q26859139-3C29C6C6-7EF5-4D51-B6D8-C475D334C1D2

P31

Q26859139-6CA7966A-0CC8-4299-8BC9-8BC0BA3BDB81

P3181

Q26859139-393ACF07-E1C0-4375-846A-21325A8A265F

P356

Q26859139-A3B81B7A-30C8-4F92-B8A9-C611DF1C4F03

P407

Q26859139-F4FCB534-8D2E-493F-BB23-E1E64B75B8C6

P433

Q26859139-7337E8B1-54E2-4D58-AD47-F1A41FBEE0C8

P478

Q26859139-E36B679A-907E-46F0-A817-8966469E985A

P50

Q26859139-03E809B5-8361-47EF-870E-8E6E13ACA684

Q26859139-0BA41EB0-D9BE-4B22-96B3-DB71E1875FD7

Q26859139-3457B2FF-112A-4728-B410-4F16C899014C

Q26859139-3BCB240B-9B24-47DA-8A0E-CD2B0877E0FA

Q26859139-64990570-05A8-4DE2-BAF5-652ED944639F

Q26859139-88CB5A08-2E39-472E-99E3-97FD49AFBE17

Q26859139-986DCC2C-D0E7-4BC5-A569-1AAC6BBB78E9

Q26859139-9ED257BE-C42A-4096-A557-D58068EFFC95

Q26859139-A910EC51-59CF-4E66-9949-F01AE94831BF

Q26859139-D52CA61D-92A2-41FA-8C9A-FD35A66CE7D4

P577

Q26859139-8AC6702F-1341-4BF0-A501-B7A2F8D7CA2C

P5875

Q26859139-FDF7A9C3-011B-4054-814F-959C9CAA87EE

P698

Q26859139-E1ECEE32-EEA1-4BFD-85FD-CBBBE87B12C7

P921

Q26859139-409680AD-8A2B-4BF6-95E9-5DDA05D04423

Q26859139-AEA2751C-9223-45D9-A829-C126EC44E4B5

P932

Q26859139-23C6D9A1-3754-485B-B25C-4AA4331FA86C

P3181

P356

P1433

Environmental Health Perspectives

P1476

Pharmaceuticals and personal c ...... t: what are the big questions?

@en

P2093

Alison McLaughlin

http://www.w3.org/2001/XMLSchema#string

Alistair B A Boxall

http://www.w3.org/2001/XMLSchema#string

Anja Coors

http://www.w3.org/2001/XMLSchema#string

Daniel J Caldwell

http://www.w3.org/2001/XMLSchema#string

Elizabeth Innes

http://www.w3.org/2001/XMLSchema#string

Frank Mastrocco

http://www.w3.org/2001/XMLSchema#string

François Gagné

http://www.w3.org/2001/XMLSchema#string

Gerald R Tetreault

http://www.w3.org/2001/XMLSchema#string

Gerald T Ankley

http://www.w3.org/2001/XMLSchema#string

Glen Van Der Kraak

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Public Domain Mark

P2860

Pyrosequencing of antibiotic-contaminated river sediments reveals high levels of resistance and gene transfer elements

Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixtures.

Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.

Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions

Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance

Generation of priority research questions to inform conservation policy and management at a national level.

Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940.

Leveraging mammalian pharmaceutical toxicology and pharmacology data to predict chronic fish responses to pharmaceuticals.

Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA National Sewage Sludge Survey.

Biotransformation of the antiviral drugs acyclovir and penciclovir in activated sludge treatment.

P304

1221-1229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1970217

http://www.w3.org/2001/XMLSchema#string

P356

10.1289/EHP.1104477

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

James M. Lazorchak

Jason P Berninger

Vance L. Trudeau

Scott E. Belanger

Jürg Oliver Straub

Bryan W. Brooks

Pedro Carriquiriborde

P577

2012-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225078241

http://www.w3.org/2001/XMLSchema#string

P698

22647657

http://www.w3.org/2001/XMLSchema#string

P921

pharmaceutical preparation

household products

P932

3440110

http://www.w3.org/2001/XMLSchema#string